Total Payments
$356,686
2024 Payments
$1,523
Companies
34
Transactions
801
Medicare Patients
8,399
Medicare Billing
$720,977
Payment Breakdown by Category
Other$199,480 (55.9%)
Consulting$102,721 (28.8%)
Travel$32,380 (9.1%)
Food & Beverage$22,105 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $197,980 | 72 | 55.5% |
| Consulting Fee | $102,721 | 54 | 28.8% |
| Travel and Lodging | $32,380 | 82 | 9.1% |
| Food and Beverage | $22,105 | 592 | 6.2% |
| Honoraria | $1,500 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $144,758 | 166 | $0 (2022) |
| Medtronic Vascular, Inc. | $77,466 | 206 | $0 (2020) |
| Biosense Webster, Inc. | $58,617 | 68 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $22,337 | 14 | $0 (2022) |
| Medical Device Business Services, Inc. | $14,960 | 18 | $0 (2022) |
| CVRx, Inc. | $13,726 | 29 | $0 (2022) |
| Abbott Laboratories | $10,494 | 103 | $0 (2024) |
| Medtronic, Inc. | $8,299 | 53 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $1,500 | 1 | $0 (2023) |
| Medtronic USA, Inc. | $1,227 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,523 | 11 | Abbott Laboratories ($1,341) |
| 2023 | $4,748 | 40 | Abbott Laboratories ($2,512) |
| 2022 | $38,630 | 120 | Biosense Webster, Inc. ($18,210) |
| 2021 | $23,998 | 55 | SANOFI-AVENTIS U.S. LLC ($8,891) |
| 2020 | $36,209 | 72 | Biosense Webster, Inc. ($17,178) |
| 2019 | $75,679 | 154 | Janssen Pharmaceuticals, Inc ($27,856) |
| 2018 | $83,719 | 171 | Janssen Pharmaceuticals, Inc ($48,430) |
| 2017 | $92,181 | 178 | Janssen Pharmaceuticals, Inc ($68,138) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | AVEIR (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/10/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/20/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/18/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/10/2024 | Abbott Laboratories | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Structural Heart | ||||||
| 08/22/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $131.23 | General |
| Category: Ablation | ||||||
| 07/30/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/13/2024 | Abbott Laboratories | AVEIR (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $38.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/20/2024 | Abbott Laboratories | AVEIR (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/30/2023 | Abbott Laboratories | AVEIR (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/16/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/19/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/19/2023 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Cardiovascular | ||||||
| 09/15/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/15/2023 | Abbott Laboratories | AVEIR (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/10/2023 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/04/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/27/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/27/2023 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/27/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/19/2023 | Medtronic, Inc. | REVEAL LINQ (Device) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/12/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 936 | 1,954 | $246,179 | $48,574 |
| 2022 | 32 | 2,294 | 5,136 | $1.1M | $229,490 |
| 2021 | 37 | 2,500 | 5,483 | $1.3M | $276,757 |
| 2020 | 32 | 2,669 | 7,334 | $816,636 | $166,157 |
Total Patients
8,399
Total Services
19,907
Medicare Billing
$720,977
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 84 | 288 | $42,912 | $10,122 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 129 | $33,540 | $9,518 | 28.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 158 | 334 | $35,738 | $5,874 | 16.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 191 | 405 | $40,905 | $5,311 | 13.0% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 61 | 264 | $22,704 | $4,336 | 19.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 64 | 72 | $15,126 | $2,981 | 19.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 32 | 179 | $15,215 | $2,939 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 51 | $8,925 | $2,620 | 29.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 34 | 76 | $14,668 | $1,690 | 11.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,200 | $1,487 | 35.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 121 | 130 | $10,140 | $1,116 | 11.0% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 13 | 14 | $2,106 | $579.04 | 27.5% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2022 | 45 | 47 | $166,850 | $40,160 | 24.1% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2022 | 11 | 11 | $219,725 | $37,996 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 253 | 320 | $83,200 | $27,918 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 111 | 128 | $44,800 | $15,000 | 33.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 198 | 609 | $65,163 | $12,577 | 19.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2022 | 94 | 652 | $56,072 | $11,735 | 20.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 240 | 757 | $76,457 | $11,716 | 15.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 136 | 167 | $34,137 | $8,979 | 26.3% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2022 | 30 | 31 | $43,245 | $7,437 | 17.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2022 | 91 | 647 | $96,403 | $7,175 | 7.4% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2022 | 43 | 310 | $26,350 | $5,318 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 352 | 509 | $39,702 | $5,047 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 79 | $13,825 | $4,850 | 35.1% |
About Dr. James Allred, MD
Dr. James Allred, MD is a Cardiovascular Disease healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669583316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Allred, MD has received a total of $356,686 in payments from pharmaceutical and medical device companies, with $1,523 received in 2024. These payments were reported across 801 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($197,980).
As a Medicare-enrolled provider, Allred has provided services to 8,399 Medicare beneficiaries, totaling 19,907 services with total Medicare billing of $720,977. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Greensboro, NC
- Active Since 08/31/2006
- Last Updated 09/27/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669583316
Products in Payments
- XARELTO (Drug) $144,797
- Carto 3 System (Device) $45,375
- CARTO 3 (Device) $19,887
- Barostim Neo System (Device) $13,726
- MULTAQ (Drug) $11,464
- Reveal LINQ (Device) $9,903
- Arctic Front (Device) $7,722
- Carto 3 (Device) $7,174
- AVEIR (Device) $4,278
- Reveal XT (Device) $4,100
- DISEASE STATE (Drug) $3,970
- Sotalol Hydrochloride (Drug) $1,500
- LIORESAL (Device) $1,227
- LINQ II (Device) $569.48
- REVEAL LINQ (Device) $547.60
- Micra (Device) $542.92
- WATCHMAN (Device) $372.69
- CareLink (Device) $341.10
- WATCHMAN DEVICE (Device) $311.29
- Azure (Device) $309.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Greensboro
Dr. Thomas Stuckey, M.d, M.D
Cardiovascular Disease — Payments: $125,136
Cardiovascular Disease $125,136
Dr. Tiffany Randolph, M.d, M.D
Cardiovascular Disease — Payments: $102,189
Cardiovascular Disease $102,189
Dalton Mclean, M.d, M.D
Cardiovascular Disease — Payments: $61,871
Cardiovascular Disease $61,871
Dr. Wesley O'neal, Md, MD
Cardiovascular Disease — Payments: $51,075
Cardiovascular Disease $51,075
Kenneth Hilty, M.d, M.D
Cardiovascular Disease — Payments: $45,620
Cardiovascular Disease $45,620
Michael Cooper, M.d, M.D
Cardiovascular Disease — Payments: $14,154
Cardiovascular Disease $14,154